| UniProt ID | TRPV2_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y5S1 | |
| Protein Name | Transient receptor potential cation channel subfamily V member 2 | |
| Gene Name | TRPV2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 764 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein. Cytoplasm. Melanosome . Translocates from the cytoplasm to the plasma membrane upon ligand stimulation (By similarity). Identified by mass spectrometry in melanosome fractions from stage I to stage IV.. |
|
| Protein Description | Calcium-permeable, non-selective cation channel with an outward rectification. Seems to be regulated, at least in part, by IGF-I, PDGF and neuropeptide head activator. May transduce physical stimuli in mast cells. Activated by temperatures higher than 52 degrees Celsius; is not activated by vanilloids and acidic pH.. | |
| Protein Sequence | MTSPSSSPVFRLETLDGGQEDGSEADRGKLDFGSGLPPMESQFQGEDRKFAPQIRVNLNYRKGTGASQPDPNRFDRDRLFNAVSRGVPEDLAGLPEYLSKTSKYLTDSEYTEGSTGKTCLMKAVLNLKDGVNACILPLLQIDRDSGNPQPLVNAQCTDDYYRGHSALHIAIEKRSLQCVKLLVENGANVHARACGRFFQKGQGTCFYFGELPLSLAACTKQWDVVSYLLENPHQPASLQATDSQGNTVLHALVMISDNSAENIALVTSMYDGLLQAGARLCPTVQLEDIRNLQDLTPLKLAAKEGKIEIFRHILQREFSGLSHLSRKFTEWCYGPVRVSLYDLASVDSCEENSVLEIIAFHCKSPHRHRMVVLEPLNKLLQAKWDLLIPKFFLNFLCNLIYMFIFTAVAYHQPTLKKQAAPHLKAEVGNSMLLTGHILILLGGIYLLVGQLWYFWRRHVFIWISFIDSYFEILFLFQALLTVVSQVLCFLAIEWYLPLLVSALVLGWLNLLYYTRGFQHTGIYSVMIQKVILRDLLRFLLIYLVFLFGFAVALVSLSQEAWRPEAPTGPNATESVQPMEGQEDEGNGAQYRGILEASLELFKFTIGMGELAFQEQLHFRGMVLLLLLAYVLLTYILLLNMLIALMSETVNSVATDSWSIWKLQKAISVLEMENGYWWCRKKQRAGVMLTVGTKPDGSPDERWCFRVEEVNWASWEQTLPTLCEDPSGAGVPRTLENPVLASPPKEDEDGASEENYVPVQLLQSN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTSPSSSPV ------CCCCCCCCE | 49.71 | 29255136 | |
| 3 | Phosphorylation | -----MTSPSSSPVF -----CCCCCCCCEE | 22.83 | 29255136 | |
| 5 | Phosphorylation | ---MTSPSSSPVFRL ---CCCCCCCCEEEE | 43.12 | 29255136 | |
| 6 | Phosphorylation | --MTSPSSSPVFRLE --CCCCCCCCEEEEE | 41.88 | 29255136 | |
| 7 | Phosphorylation | -MTSPSSSPVFRLET -CCCCCCCCEEEEEE | 29.44 | 29255136 | |
| 14 | Phosphorylation | SPVFRLETLDGGQED CCEEEEEECCCCCCC | 34.44 | 29083192 | |
| 23 | Phosphorylation | DGGQEDGSEADRGKL CCCCCCCCHHHCCCC | 41.77 | 30108239 | |
| 49 | Ubiquitination | QFQGEDRKFAPQIRV HHCCCCCCCCCEEEE | 59.19 | - | |
| 60 | Phosphorylation | QIRVNLNYRKGTGAS EEEEECCCCCCCCCC | 19.50 | - | |
| 67 | Phosphorylation | YRKGTGASQPDPNRF CCCCCCCCCCCCCCC | 43.52 | 22985185 | |
| 84 | Phosphorylation | DRLFNAVSRGVPEDL HHHHHHHHCCCCHHH | 22.40 | - | |
| 100 | Ubiquitination | GLPEYLSKTSKYLTD CCHHHHHHHCCCCCC | 54.98 | 29967540 | |
| 103 | Ubiquitination | EYLSKTSKYLTDSEY HHHHHHCCCCCCCCC | 49.89 | - | |
| 104 | Phosphorylation | YLSKTSKYLTDSEYT HHHHHCCCCCCCCCC | 18.01 | 27642862 | |
| 110 | Phosphorylation | KYLTDSEYTEGSTGK CCCCCCCCCCCCCCC | 17.65 | 27642862 | |
| 114 | Phosphorylation | DSEYTEGSTGKTCLM CCCCCCCCCCCHHHH | 27.96 | 30576142 | |
| 115 | Phosphorylation | SEYTEGSTGKTCLMK CCCCCCCCCCHHHHH | 54.26 | 30576142 | |
| 117 | Ubiquitination | YTEGSTGKTCLMKAV CCCCCCCCHHHHHHH | 35.83 | - | |
| 173 | Ubiquitination | ALHIAIEKRSLQCVK HHHHHHHHCCHHHHH | 40.97 | 29967540 | |
| 200 | Ubiquitination | ACGRFFQKGQGTCFY CCHHHCCCCCCEEEE | 48.31 | - | |
| 231 | Ubiquitination | VVSYLLENPHQPASL HHHHHHCCCCCCCCC | 39.05 | 22817900 | |
| 234 | Ubiquitination | YLLENPHQPASLQAT HHHCCCCCCCCCEEE | 36.19 | 22817900 | |
| 299 | Ubiquitination | LQDLTPLKLAAKEGK CCCCCHHHHHHHHCC | 36.96 | 22817900 | |
| 303 | Ubiquitination | TPLKLAAKEGKIEIF CHHHHHHHHCCHHHH | 62.48 | 22817900 | |
| 327 | Ubiquitination | GLSHLSRKFTEWCYG CCHHHHHHHHHHHHC | 53.94 | 21906983 | |
| 378 | Ubiquitination | VVLEPLNKLLQAKWD EEEHHHHHHHHHHHH | 59.25 | 21890473 | |
| 383 | Ubiquitination | LNKLLQAKWDLLIPK HHHHHHHHHHHHHHH | 28.42 | 22817900 | |
| 401 | Phosphorylation | NFLCNLIYMFIFTAV HHHHHHHHHHHHHHH | 6.80 | - | |
| 406 | Phosphorylation | LIYMFIFTAVAYHQP HHHHHHHHHHHHCCC | 18.53 | - | |
| 430 | Phosphorylation | LKAEVGNSMLLTGHI CCCHHCCHHHHHHHH | 12.60 | 24043423 | |
| 434 | Phosphorylation | VGNSMLLTGHILILL HCCHHHHHHHHHHHH | 23.81 | 24043423 | |
| 445 | Phosphorylation | LILLGGIYLLVGQLW HHHHHHHHHHHHHHH | 9.39 | 24043423 | |
| 453 | Phosphorylation | LLVGQLWYFWRRHVF HHHHHHHHHHHHHHH | 11.23 | 24043423 | |
| 523 | Phosphorylation | GFQHTGIYSVMIQKV CCCCCCHHHHHHHHH | 9.14 | 22817900 | |
| 524 | Phosphorylation | FQHTGIYSVMIQKVI CCCCCHHHHHHHHHH | 11.86 | 22817900 | |
| 526 | Sulfoxidation | HTGIYSVMIQKVILR CCCHHHHHHHHHHHH | 1.90 | 31719194 | |
| 567 | Phosphorylation | AWRPEAPTGPNATES HHCCCCCCCCCCCCC | 72.77 | 22210691 | |
| 570 | N-linked_Glycosylation | PEAPTGPNATESVQP CCCCCCCCCCCCCCC | 61.92 | UniProtKB CARBOHYD | |
| 572 | Phosphorylation | APTGPNATESVQPME CCCCCCCCCCCCCCC | 35.12 | 22210691 | |
| 574 | Phosphorylation | TGPNATESVQPMEGQ CCCCCCCCCCCCCCC | 23.00 | 22210691 | |
| 590 | Phosphorylation | DEGNGAQYRGILEAS CCCCCHHHHHHHHHH | 15.40 | 22210691 | |
| 607 | Sulfoxidation | LFKFTIGMGELAFQE HHHHCCCCCHHHHHH | 3.13 | 31719194 | |
| 660 | Ubiquitination | ATDSWSIWKLQKAIS HHCHHHHHHHHHHHH | 6.98 | 22817900 | |
| 661 | Ubiquitination | TDSWSIWKLQKAISV HCHHHHHHHHHHHHH | 39.09 | 22817900 | |
| 663 | Ubiquitination | SWSIWKLQKAISVLE HHHHHHHHHHHHHHC | 29.43 | 22817900 | |
| 664 | Acetylation | WSIWKLQKAISVLEM HHHHHHHHHHHHHCC | 59.11 | 12655291 | |
| 664 | Ubiquitination | WSIWKLQKAISVLEM HHHHHHHHHHHHHCC | 59.11 | 22817900 | |
| 733 | Phosphorylation | SGAGVPRTLENPVLA CCCCCCCCCCCCCCC | 32.14 | 26074081 | |
| 741 | Phosphorylation | LENPVLASPPKEDED CCCCCCCCCCCCCCC | 37.26 | 28796482 | |
| 751 | Phosphorylation | KEDEDGASEENYVPV CCCCCCCCCCCCCCH | 51.47 | 23898821 | |
| 755 | Phosphorylation | DGASEENYVPVQLLQ CCCCCCCCCCHHHHC | 14.92 | 26657352 | |
| 763 | Phosphorylation | VPVQLLQSN------ CCHHHHCCC------ | 44.47 | 26074081 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRPV2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRPV2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRPV2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of TRPV2_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-523 AND SER-524, ANDMASS SPECTROMETRY. | |